Article
Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients.
PloS one - 1 Jan 2015
Wang Jing-Han, Guo Qi, Ma Zhi-Xin, Ma Qiu-Ling, Yu Meng-Xia, Yin Xiu-Feng, Lu Sha-Sha, Xie Hong-Qiong, Jiang Yue-Hong, Shen Dan, Ma Li-Ya, Shi Hui, Yu Wen-Juan, Lou Ye-Jiang, Li Ying, Yang Min, Xu Gai-Xiang, Mao Li-Ping, Li Jian-Hu, Wang Huan-Ping, Wang Dong-Mei, Wei Ju-Ying, Tong Hong-Yan, Huang Jian, Jin Jie
Abstract excerpt
The effect of time from diagnosis to treatment (TDT) on overall survival of patients with acute myeloid leukemia (AML) remains obscure. Furthermore, whether chemotherapy delay impacts overall survival (OS) of patients with a special molecular subtype has not been investigated. Here, we enrolled 364 cases of AML to assess the effect of TDT on OS by fractional polynomial regression in the context of clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.